medigraphic.com
ISSN 2448-8909 (Print)

2009, Number 3

<< Back Next >>

Med Crit 2009; 23 (3)

Induced cardiopulmonary damage by blood transfusion in post-heart surgery patients

Santillano GE, Reyna SJL, Villalobos SJA

Language: Spanish
References: 31
Page: 154-164
PDF size: 101.64 Kb.


ABSTRACT

Prophylactic use of transfusion of blood products is not indicated in modern cardiac surgery. Bleeding after cardiac surgery is very common, 10-25% of transfusion of blood products annually in the United States are in heart surgery. Reducing blood transfusion for their side effects and the risk that patients may develop after it has become a priority in Intensive Care Units Post-surgical. The acute lung injury in post-heart surgery related to transfusion (LPART) is a form of lung injury associated with the transfusion and is one of the most serious transfusion reactions and the second cause of death for transfusion. The damage cardiopulmonary secondary to transfusion is increasingly reported in our Units, acute lung injury or «alveolar edema low pressure» associated with the transfusion is one of the principal causes of morbility and prolonged stay.


REFERENCES

  1. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-1507.

  2. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-136.

  3. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001;71:769-776.

  4. Fang WC, Helm RE, Krieger KH, Rosengart TK, DuBois WJ, Sason C et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997;96(Suppl 2):194-199.

  5. Fillinger MP, Surgenor SD, Clark C, Hartman GS, Paganelli WC. The impact on mortality of managing hemodilutional anemia with RBC transfusion after CABG. Anesthesiology 2001;95:A201.

  6. Gong MN, Thompson BT, Williams P et al. Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion. Crit Care Med 2005;33:1191-1198.

  7. Khan H, Belsher J, Yilmaz M et al. Fresh frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007;131:1308-1314.

  8. Zilberberg MD, Carter C, Lefebvre P et al. Red blood cell transfusions and the risk of ARDS amongst critically ill: A cohort study. Crit Care 2007;11:R63-doi:10.1186/cc5934.

  9. Hardy JF, Martineau R, Couturier A, Belisle S, Cartier R, Carrier M. Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery. Br J Anaesth 1998;81(Suppl 1):38-45.

  10. Weiskopf RB. More on the changing indications for transfusion of blood and blood components during anesthesia. Anesthesiology 1996;84:498-501.

  11. A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy Practice guidelines for blood component therapy. Anesthesiology 1996;84:732-747.

  12. Saxena S, Wehrli G, Makarewicz K, Sartorelli J, Shulman IA. Monitoring for underutilization of RBC components and platelets. Transfusion 2001;41:587-590.

  13. Spahn DR, Schmid ER, Seifert B, Pasch T. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 1996;82:687-694.

  14. Spahn DR, Casutt M. Eliminating blood transfusions: New aspects and perspectives. Anesthesiology 2000;93: 242-255.

  15. Zollinger A, Hager P, Singer T, Friedl HP, Pasch T, Spahn DR. Extreme hemodilution due to blood loss in tumor surgery. Anesthesiology 1997;87:985-987.

  16. Hill SE, van Wermeskerken GK, Lardenoye JW, Phillips-Bute B, Smith PK, Reves JG et al. Intraoperative physiologic variables and outcome in cardiac surgery: part I. In-hospital mortality. Ann Thorac Surg 2000;69:1070-1076.

  17. Silliman CC, Paterson AJ, Dickey WO et al: The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion 1997;37:719-726.

  18. Wallis JP, Lubenko A, Wells AW et al. Single hospital experience of TRALI. Transfusion 2003;43:1053-1059.

  19. Cajic O, Rana R, Winters JL et al. Transfusion related acute lung injury in the critically ill: Prospective nested case-control study. Am J Respir Crit Care Med 2007;176: 886-891.

  20. Fadeyi EA, De Los Angeles MM, Wayne AS et al. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007;47:545-550.

  21. Curtis BR, McFarland JG. Mechanisms of transfusion-related acute lung injury (TRALI): Anti-leukocyte antibodies. Crit Care Med 2006;34:S118-S123.

  22. Shander A, Popovsky MA. Understanding the consequences of transfusion-related acute lung injury. Chest 2005;128:598S-604S.

  23. Bux J, Sachs UJ. The pathogenesis of transfusion- related acute lung injury (TRALI). Br J Haematol 2007;136: 788-799.

  24. He´bert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227-232.

  25. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP et al. Comparison of two fluid management strategies in acute lung injury. N Engl J Med 2006;354:2564-2575.

  26. Netzer G, Shah CV, Iwashyna TJ et al. Association of red cell transfusion with mortality in patients with acute lung injury. Chest 2007;132:1116-1123.

  27. Ashbaugh DG, Bigelow DB, Petty TL et al. Acute respiratory distress in adults. Lancet 1967;1:319-323.

  28. Miller PR, Croce MA, Kilgo PD et al. Acute respiratory distress syndrome in blunt trauma: Identification of independent risk factors. Am Surg 2002;68:845-850.

  29. Spahn DR, Schanz U, Pasch T. Perioperative transfusions kriterien. Anaesthesist 1998;47:1011-1120.

  30. London MJ, Hollenberg M, Wong MG, Levenson L, Tubau JF, Browner W et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 1988;69:232-241.

  31. Bak Z, Abildgard L, Lisander B, Janerot-Sjoberg B. Transesophageal echocardiographic hemodynamic monitoring during preoperative acute normovolemic hemodilution. Anesthesiology 2000;92:1250-1256.




2020     |     www.medigraphic.com